Distinct Mechanisms of Receptor and Nonreceptor Tyrosine Kinase Activation by Reactive Oxygen Species in Vascular Smooth Muscle Cells: Role of Metalloprotease and Protein Kinase C-δ
- 1 March 2003
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 23 (5) , 1581-9
- https://doi.org/10.1128/mcb.23.5.1581-1589.2003
Abstract
Reactive oxygen species (ROS) are implicated in cardiovascular diseases. ROS, such as H2O2, act as second messengers to activate diverse signaling pathways. Although H2O2 activates several tyrosine kinases, including the epidermal growth factor (EGF) receptor, JAK2, and PYK2, in vascular smooth muscle cells (VSMCs), the intracellular mechanism by which ROS activate these tyrosine kinases remains unclear. Here, we identified two distinct signaling pathways required for receptor and nonreceptor tyrosine kinase activation by H2O2 involving a metalloprotease-dependent generation of heparin-binding EGF-like growth factor (HB-EGF) and protein kinase C (PKC)-delta activation, respectively. H2O2-induced EGF receptor tyrosine phosphorylation was inhibited by a metalloprotease inhibitor, whereas the inhibitor had no effect on H2O2-induced JAK2 tyrosine phosphorylation. HB-EGF neutralizing antibody inhibited H2O2-induced EGF receptor phosphorylation. In COS-7 cells expressing an HB-EGF construct tagged with alkaline phosphatase, H2O2 stimulates HB-EGF production through metalloprotease activation. By contrast, dominant negative PKC-delta transfection inhibited H2O2-induced JAK2 phosphorylation but not EGF receptor phosphorylation. Dominant negative PYK2 inhibited H2O2-induced JAK2 activation but not EGF receptor activation, whereas dominant negative PKC-delta inhibited PYK2 activation by H2O2. These data demonstrate the presence of distinct tyrosine kinase activation pathways (PKC-delta/PYK2/JAK2 and metalloprotease/HB-EGF/EGF receptor) utilized by H2O2 in VSMCs, thus providing unique therapeutic targets for cardiovascular diseases.Keywords
This publication has 73 references indexed in Scilit:
- Unique Regulation of c-Jun N-Terminal Kinase by PYK2/CAK-β in Angiotensin II-Stimulated Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2001
- A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth FactorJournal of Biological Chemistry, 2001
- N-Acetylcysteine Inhibits Angiotensin II-Mediated Activation of Extracellular Signal-Regulated Kinase and Epidermal Growth Factor ReceptorBiochemical and Biophysical Research Communications, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- H2O2-Induced Tyrosine Phosphorylation of Protein Kinase Cδ by a Mechanism Independent of Inhibition of Protein-Tyrosine Phosphatase in CHO and COS-7 CellsBiochemical and Biophysical Research Communications, 2000
- Phosphorylation of Hic‐5 at tyrosine 60 by CAKβ and FynFEBS Letters, 2000
- PYK2/CAKβ Represents a Redox-Sensitive Tyrosine Kinase in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2000
- Reactive Oxygen Species as Mediators of Signal Transduction in Cardiovascular DiseaseTrends in Cardiovascular Medicine, 1998
- Angiotensin II Signaling in Vascular Smooth MuscleHypertension, 1997
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994